Literature DB >> 9930069

Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach.

I O Baas1, B P van Rees, A Musler, M E Craanen, G N Tytgat, F M van den Berg, G J Offerhaus.   

Abstract

AIM: To evaluate similarities and differences between gastric stump cancer and conventional carcinoma in the non-operated stomach.
METHODS: 26 stump carcinomas were compared with 24 conventional stomach cancers. Stage, histological type, and demographics were comparable in the two groups. Expression of p53 and p21-Waf1/Cip1 was evaluated by immunohistochemical staining. Helicobacter pylori infection was evaluated by examining haematoxylin-eosin stained slides and immunohistochemistry. Epstein-Barr virus infection was evaluated by RNA in situ hybridisation.
RESULTS: Expression of p53 and p21-Waf1/Cip1 was similar in both groups and positive in more than half of the patients. H pylori infection was observed in six stump carcinomas and 17 conventional carcinomas in the intact stomach (p < 0.01). RNA in situ hybridisation (EBER1-ISH) for Epstein-Barr virus was positive in nine stump carcinomas and two carcinomas in the non-operated stomach (p < 0.05).
CONCLUSIONS: There appear to be aetiological differences between stump carcinoma and cancer in the intact stomach. Further study of these differences may improve our understanding of gastric carcinogenesis in general.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9930069      PMCID: PMC500902          DOI: 10.1136/jcp.51.9.662

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  31 in total

1.  Chemotherapy for gastric cancer.

Authors:  A Saini; J Waxman
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

2.  Trends of cancer mortality in Europe, 1955-1989: I, Digestive sites.

Authors:  C La Vecchia; F Lucchini; E Negri; P Boyle; P Maisonneuve; F Levi
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

3.  Mortality from gastric cancer following gastric surgery for peptic ulcer.

Authors:  C P Caygill; M J Hill; J S Kirkham; T C Northfield
Journal:  Lancet       Date:  1986-04-26       Impact factor: 79.321

4.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

5.  Long-term prognosis after partial gastrectomy for benign conditions. Survival and smoking-related death of 2633 Amsterdam postgastrectomy patients followed up since surgery between 1931 and 1960.

Authors:  A C Tersmette; G J Offerhaus; F M Giardiello; R Brand; K W Tersmette; G N Tytgat; J P Vandenbroucke
Journal:  Gastroenterology       Date:  1991-07       Impact factor: 22.682

6.  Prospective comparative study of the influence of postoperative bile reflux on gastric mucosal histology and Campylobacter pylori infection.

Authors:  G J Offerhaus; P N Rieu; J B Jansen; H J Joosten; C B Lamers
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

7.  Evaluation of endoscopy for early detection of gastric-stump cancer.

Authors:  G J Offerhaus; A C Tersmette; F M Giardiello; K Huibregtse; J P Vandenbroucke; G N Tytgat
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

8.  Multivariate analysis of the risk of stomach cancer after ulcer surgery in an Amsterdam cohort of postgastrectomy patients.

Authors:  A C Tersmette; S N Goodman; G J Offerhaus; K W Tersmette; F M Giardiello; J P Vandenbroucke; G N Tytgat
Journal:  Am J Epidemiol       Date:  1991-07-01       Impact factor: 4.897

9.  The mucosa of the gastric remnant harboring malignancy. Histologic findings in the biopsy specimens of 504 asymptomatic patients 15 to 46 years after partial gastrectomy with emphasis on nonmalignant lesions.

Authors:  G J Offerhaus; J van de Stadt; K Huibregtse; A C Tersmette; G N Tytgat
Journal:  Cancer       Date:  1989-08-01       Impact factor: 6.860

10.  Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years of follow up of an Amsterdam cohort of 2633 postgastrectomy patients.

Authors:  G J Offerhaus; A C Tersmette; K Huibregtse; J van de Stadt; K W Tersmette; T Stijnen; P J Hoedemaeker; J P Vandenbroucke; G N Tytgat
Journal:  Gut       Date:  1988-11       Impact factor: 23.059

View more
  15 in total

1.  Epstein-Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma.

Authors:  Yasuharu Kaizaki; Osamu Hosokawa; Shinji Sakurai; Masashi Fukayama
Journal:  J Gastroenterol       Date:  2005-06       Impact factor: 7.527

2.  Incidence and clinical features of endoscopic ulcers developing after gastrectomy.

Authors:  Woo Chul Chung; Eun Jung Jeon; Kang-Moon Lee; Chang Nyol Paik; Sung Hoon Jung; Jung Hwan Oh; Ji Hyun Kim; Kyong-Hwa Jun; Hyung Min Chin
Journal:  World J Gastroenterol       Date:  2012-07-07       Impact factor: 5.742

Review 3.  Gastroenterostoma after Billroth antrectomy as a premalignant condition.

Authors:  Robert Sitarz; Ryszard Maciejewski; Wojciech P Polkowski; G Johan A Offerhaus
Journal:  World J Gastroenterol       Date:  2012-07-07       Impact factor: 5.742

4.  Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.

Authors:  Gwen Murphy; Ruth Pfeiffer; M Constanza Camargo; Charles S Rabkin
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

5.  Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis.

Authors:  A Zur Hausen; B P van Rees; J van Beek; M E Craanen; E Bloemena; G J A Offerhaus; C J L M Meijer; A J C van den Brule
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

6.  Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway.

Authors:  Bastiaan P van Rees; Eric Caspers; Axel zur Hausen; Adriaan van den Brule; Paul Drillenburg; Marian A J Weterman; G Johan A Offerhaus
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

7.  Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.

Authors:  Q N Vo; J Geradts; M L Gulley; D A Boudreau; J C Bravo; B G Schneider
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

8.  Construction and Antiapoptosis Activities of Recombinant Adenoviral Expression Vector Carrying EBV Latent Membrane Protein 2A.

Authors:  Xishuang Liu; Yu Gao; Bing Luo; Youan Zhao
Journal:  Gastroenterol Res Pract       Date:  2011-08-16       Impact factor: 2.260

9.  Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.

Authors:  Jing Han; Jian-ning Chen; Zhi-gang Zhang; Hai-gang Li; Yun-gang Ding; Hong Du; Chun-kui Shao
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

10.  Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.

Authors:  Jian-ning Chen; Na-na Zhang; Ye Jiang; Da-yang Hui; Zi-jin Wen; Hai-gang Li; Yun-gang Ding; Hong Du; Chun-kui Shao
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.